Serafin Andrew — SEC Form 4 filings

SEC reporting owner CIK 1821460. 3 Form 4 filings on record with FilingPulse; latest filed 2026-01-26.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-01-26 to 2026-01-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Harmony Biosciences Holdings, Inc. (HRMY)CHIEF STRATEGY OFFICER315

Form 4 filings — Serafin Andrew

FiledFormIssuerReported transactionsSource
2026-01-264Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 2,500 @ $0 · Tax withholding (F): 1,116 @ $36.82 · Option exercise (M): 2,600 @ $0 · Tax withholding (F): 1,126 @ $36.82 · Grant/award (A): 42,600 (derivative) @ $0 · Grant/award (A): 12,200 (derivative) @ $0 · +2 moreEDGAR
2025-01-284Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 2,500 @ $0 · Tax withholding (F): 865 @ $38.01 · Option exercise (M): 2,500 (derivative) @ $0 · Grant/award (A): 36,500 (derivative) @ $0 · Grant/award (A): 10,400 (derivative) @ $0EDGAR
2024-01-264Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 47,750 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1821460 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →